David J. Brooks
David J. Brooks publishes mostly in Neurology, Cellular and Molecular Neuroscience and Radiology, Nuclear Medicine and Imaging, on topics such as Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments and Alzheimer's disease research and treatments.
- World rank
- #42,982 of 7,710,434 ranked researchers
- Rank in United Kingdom
- #3,421 of 367,258
- Works
- 1,289
- Citations
- 106k
- Citations per work
- 82.6
What does David J. Brooks research?
David J. Brooks's work is mostly in Medicine (41%), Neuroscience (15%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else56143.5%
- Health Sciences53141.2%
- Medicine53141.2%
- Life Sciences19715.3%
- Neuroscience19715.3%
- 1Neurology26% of their works
- 2Cellular and Molecular Neuroscience10% of their works
- 3Radiology, Nuclear Medicine and Imaging6% of their works
- 4Neurology5% of their works
- 5Physiology5% of their works
- 6Psychiatry and Mental health4% of their works
Research topics
- Parkinson's Disease Mechanisms and Treatments
- Neurological disorders and treatments
- Alzheimer's disease research and treatments
- Genetic Neurodegenerative Diseases
- Neuroscience and Neuropharmacology Research
- Dementia and Cognitive Impairment Research
- Medical Imaging Techniques and Applications
- Neuroinflammation and Neurodegeneration Mechanisms
Which keywords describe David J. Brooks's research?
The keywords of their largest research topics: Parkinson's Disease, Neurodegeneration, Oxidative Stress, Mitochondrial Dysfunction, Neurological Disorders, a-Synuclein, Dopaminergic Neurons and Deep Brain Stimulation.
- Microglia
- PET/CT
- Mild Cognitive Impairment
- Synaptic Plasticity
- Protein Aggregation
- Tau Pathology
- Neuroinflammation
- Deep Brain Stimulation
- Dopaminergic Neurons
- Mitochondrial Dysfunction
- Neurodegeneration
- Parkinson's Disease
- Oxidative Stress
- Neurological Disorders
- a-Synuclein
- Subthalamic Nucleus
- Amyloid Hypothesis
- Huntington's Disease
- Neurotransmission
- Alzheimer's Disease
- Imaging
- Astrocytes
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Parkinson's Disease7502 topics
- Neurodegeneration5613 topics
- Oxidative Stress4952 topics
- Mitochondrial Dysfunction4922 topics
- Neurological Disorders4672 topics
- Dopaminergic Neurons3791 topic
- a-Synuclein3791 topic
- Deep Brain Stimulation3711 topic
- Subthalamic Nucleus3711 topic
- Neuroinflammation1822 topics
- Amyloid Hypothesis1161 topic
- Tau Pathology1161 topic
- Huntington's Disease1131 topic
- Protein Aggregation1131 topic
- Neurotransmission961 topic
- Synaptic Plasticity961 topic
- Alzheimer's Disease891 topic
- Mild Cognitive Impairment891 topic
- Imaging791 topic
- PET/CT791 topic
- Astrocytes661 topic
- Microglia661 topic
Where does David J. Brooks work?
David J. Brooks's main affiliation in the publication record is Hammersmith Hospital, United Kingdom.
How many publications and citations does David J. Brooks have?
OpenAlex counts 1,289 works and 106,485 citations for David J. Brooks, an h-index of 159, ranking #42,982 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named David J. Brooks
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about David J. Brooks. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.